2020-11-09T10:45:24-06:00 2020-06-30 953001179 WINDES INC PO BOX 87 LONG BEACH CA 908010087 990 2019-07-01 330841281 PANCREATIC CANCER ACTION NETWORK INC PANC 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 THOMAS V CROAL CFO 3107250025 2020-11-03 1 DONITA M JOSEPH P00286656 5624351191 2020-10-23 162.255.181.42 2020-11-03 16:39:23 PS P 34807A00DB7E8CE0F77EA9408E55F201CB9C4E9C 011948D047ED9261A63A56FF7675BE1E9BE374B0 2019 2021-01-29 14:40:06Z JULIE FLESHMAN 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 49254624 0 X WWW.PANCAN.ORG X 1999 CA TO ADVANCE RESEARCH, SUPPORT PATIENTS, AND CREATE HOPE FOR PEOPLE WHO HAVE PANCREATIC CANCER. 12 11 194 5758 0 0 41998702 35529596 1004290 1187016 868740 1140228 -2171450 -1219565 41700282 36637275 5818967 6003848 0 0 15562510 18638131 0 0 4775830 14596577 17682654 35978054 42324633 5722228 -5687358 65075415 60854270 16038137 17601640 49037278 43252630 X OUR MISSION IS TO TAKE BOLD ACTION TO IMPROVE THE LIVES OF EVERYONE IMPACTED BY PANCREATIC CANCER BY ADVANCING SCIENTIFIC RESEARCH, BUILDING COMMUNITY, SHARING KNOWLEDGE, AND ADVOCATING FOR PATIENTS. 0 0 20745222 6003848 1000000 RESEARCH GRANTS AND CLINICAL INITIATIVES - PANCAN'S RESEARCH GRANTS AND CLINICAL INITIATIVES ARE CHANGING THE LANDSCAPE OF PANCREATIC CANCER RESEARCH. THE RESEARCH GRANTS DEPARTMENT ADMINISTERS A COMPETITIVE GRANTS PROGRAM, AWARDING THE MOST MERITORIOUS RESEARCH PROJECTS WITH A FOCUS ON THOSE THAT ADVANCE OUR CLINICAL INITIATIVES, TO THE BRIGHTEST SCIENTISTS, TO TRANSLATE THE BEST RESEARCH INTO THE CLINIC. TO DATE THE GRANTS PROGRAM HAS FUNDED 184 GRANTS, TOTALING OVER $52M IN FUNDING, WHICH WAS DISTRIBUTED TO 179 SCIENTISTS AT 70 INSTITUTIONS AROUND THE COUNTRY. GROUNDBREAKING INITIATIVES LIKE OUR "KNOW YOUR TUMOR" PRECISION MEDICINE SERVICE, AND PRECISION PROMISE, AN INNOVATIVE CLINICAL TRIAL PLATFORM FOR PATIENTS WITH PANCREATIC CANCER, PLAY A PIVOTAL ROLE IN CHANGING OUTCOMES FOR PATIENTS. IN ADDITION, AGREEMENTS FOR THE PRECISION PROMISE PROGRAM AND SUPPORT FOR OTHER PRIORITY CLINICAL INITIATIVES TOTALED ABOUT $1.5M AND HAVE BEEN INCLUDED IN RESEARCH FOR THIS FISCAL YEAR. 1283742 187016 GOVERNMENT AFFAIRS AND ADVOCACY - WE DRIVE LEGISLATIVE SUPPORT FOR INCREASED FEDERAL RESEARCH FUNDING - CRITICAL BECAUSE APPROXIMATELY 80 PERCENT OF ALL PANCREATIC CANCER RESEARCH FUNDING COMES FROM THE FEDERAL GOVERNMENT. WE LED THE FIGHT TO PASS THE RECALCITRANT CANCER RESEARCH ACT IN CONGRESS, MAKING PANCREATIC CANCER A NATIONAL PRIORITY, AND ESTABLISHING A SCIENTIFIC FRAMEWORK TO RESEARCH THE DISEASE. OUR GRASSROOTS NETWORK AND ADVOCACY EFFORTS ON CAPITOL HILL LED TO THE CREATION OF THE FIRST EVER DEDICATED PANCREATIC CANCER RESEARCH PROGRAM AT THE DOD WHICH ALLOWS CONGRESS TO DIRECT FOCUSED FUNDING TO PANCREATIC CANCER RESEARCH. ALONG WITH OUR SUPPORTERS, WE HAVE CREATED A GRASSROOTS MOVEMENT - TELLING OUR STORIES TO CONGRESS IN AN EFFORT TO RAISE MORE AWARENESS ABOUT PANCREATIC CANCER, AND IN TURN, THE CRITICAL NEED FOR MORE RESEARCH FUNDING. AS OF 2017, NCI FUNDING FOR PANCREATIC CANCER RESEARCH HAD INCREASED TO MORE THAN $177 MILLION. 4142739 PATIENT SERVICES (PATIENT CENTRAL) - PATIENT CENTRAL IS A COMPREHENSIVE SERVICE PROVIDING IMMEDIATE AND FREE INFORMATION AND EDUCATION ABOUT PANCREATIC CANCER, DIAGNOSIS, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP THEM MAKE INFORMED DECISIONS WITH THEIR HEALTHCARE TEAM. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE PATIENTS WITH PERSONALIZED CLINICAL TRIAL SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR PATIENT CENTRAL STAFF - MADE UP OF EXPERT, UNDERSTANDING, COMPASSIONATE PEOPLE - SHARES MORE RESOURCES AND SPEAKS WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER CANCER ORGANIZATION IN THE WORLD. OUR PATIENT REGISTRY, AN ACTIVE DATABASE OF PATIENT INFORMATION, WAS DEVELOPED TO HELP ADVANCE RESEARCH AND IMPROVE CARE FOR PATIENTS BATTLING PANCREATIC CANCER. 7619066 37135 COMMUNITY ENGAGEMENT - WITH 61 AFFILIATES AND A VOLUNTEER CORPS OF MORE THAN 4,300 PEOPLE, WE RAISE FUNDS AND NATIONAL AWARENESS OF THE DISEASE THROUGH OUR PURPLESTRIDE RUN/WALK EVENTS IN COMMUNITIES NATIONWIDE. OVER 61,384 PARTICIPANTS HAVE ATTENDED OUR SIGNATURE EVENTS THIS PAST YEAR. OUR GRASSROOTS EFFORTS HARNESS THE PASSION, POWER AND ENERGY OF DEDICATED VOLUNTEERS - MANY OF WHOM HAVE LOST LOVED ONES TO THE DISEASE AND ARE COMMITTED TO FIGHTING BACK. OUR ADVOCACY EFFORTS HAVE ALSO RESULTED IN A GLOBAL MOVEMENT - WE PLAYED A LEAD ROLE IN THE CREATION OF THE WORLD PANCREATIC CANCER COALITION WHICH IS COMPOSED OF MORE THAN 90 PANCREATIC CANCER PATIENT GROUPS FROM MORE THAN 30 COUNTRIES ON 6 CONTINENTS. THE COALITION HAS TWO MAJOR INITIATIVES - A GLOBAL DAY OF AWARENESS THAT TAKES PLACE ON THE THIRD THURSDAY OF NOVEMBER, PANCREATIC CANCER AWARENESS MONTH, AND AN ANNUAL FACE-TO-FACE MEETING FOR COALITION MEMBERS TO NETWORK, SHARE EXPERIENCES AND BEST PRACTICES. THE ANNUAL FACE-TO-FACE MEETING WAS NOT HELD DUE TO COVID-19 PANDEMIC. INSTEAD A SERIES OF VIRTUAL MEETINGS AND WEBINARS WERE HOSTED TO MAINTAIN MOMENTUM AND COLLABORATION. 7619066 37135 33790769 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 142 0 1 194 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 X 12 11 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY HI X X THOMAS V CROAL CFO 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 JULIE FLESHMAN PRESIDENT & CEO/ DIRECTOR/EX-OFFICIO 50.00 X X 584553 0 30023 JEANNE WEAVER RUESCH CHAIRMAN 2.00 X X 0 0 0 HILARIE KOPLOW-MC ADAMS VICE CHAIRMAN 2.00 X X 0 0 0 KAREN YOUNG CPA BOARD MEMBER 2.00 X 0 0 0 PETER CASHION BOARD MEMBER 2.00 X 0 0 0 SCOTT A GRISWOLD CPA BOARD MEMBER 2.00 X 0 0 0 BARBARA J KENNER PHD BOARD MEMBER 2.00 X 0 0 0 MICHAEL AG KORENGOLD BOARD MEMBER 2.00 X 0 0 0 JASON KUHN BOARD MEMBER 2.00 X 0 0 0 LISA KULOK BOARD MEMBER 2.00 X 0 0 0 TERRENCE MECK BOARD MEMBER 2.00 X 0 0 0 CRAIG A ROGERSON BOARD MEMBER 2.00 X 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 50.00 X 342396 0 23246 VICTORIA MANAX CHIEF MEDICAL OFFICER (FORMER) 50.00 X 359166 0 25483 THOMAS CROAL CFO 50.00 X 303725 0 30884 SUDHEER DOSS CHIEF DATA OFFICER 50.00 X 458721 0 21338 LORI STEVENS CHIEF DEVELOPMENT & COMMUNITY ENGAGEMENT OFFICER 50.00 X 304800 0 22236 EDWINA MOSSETT CHIEF PEOPLE OFFICER 50.00 X 282179 0 21717 CHRISTINE DITTMER VICE PRESIDENT, NATIONAL LEADERSHIP GIVING 50.00 X 280439 0 19159 RICHARD LEONARD NATIONAL DIRECTOR, LEADERSHIP GIVING 50.00 X 254796 0 21742 3170775 0 215828 36 0 1 0 COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540 CRO SERVICES 3973981 FRED HUTCHINSON CANCER RESEARCH CENTER PO BOX 19024 SEATTLE WA 98109 CLINICAL RESEARCH 1247000 UNIVERSITY OF ROCHESTER 910 GENESEE STREET SUITE 200 ROCHESTER NY 14611 CLINICAL RESEARCH 981930 AACR DEVELOPMENT DEPT 615 CHESTNUT ST PHILDELPHIA PA 19106 GRANT PEER REVIEW & ADMIN 895000 PERSONALIZED CANCER THERAPY INC 1616 ANDERSON ROAD MCLEAN VA 22102 CLINICAL RESEARCH 817269 32 160259 13237971 22131366 345289 35529596 PATIENT SERVICES 900099 1000000 1000000 GOV'T AFFAIRS AND ADVOCACY 900099 187016 187016 1187016 907982 907982 11528523 11296277 232246 232246 232246 0 13237971 1277100 -1277100 -1277100 81107 43972 37135 37135 OTHER INCOME 900099 20400 20400 20400 36637275 1224151 0 -116472 X 6003848 6003848 1902559 1323492 268795 310272 14532953 10096928 2063036 2372989 197180 137913 27282 31985 899047 628819 124393 145835 1106392 773842 153081 179469 124256 108883 9657 5716 31500 27603 2448 1449 98429 98429 165822 165822 9921927 8849293 207971 864663 588377 544730 14425 29222 342284 265600 17401 59283 993874 707519 138454 147901 1305863 916089 182793 206981 506645 424258 3439 78948 957202 888960 68242 748862 673839 35170 39853 206264 172925 15625 17714 BANK AND PROCESSING FEE 775438 543202 109944 122292 STAFF SUPPORT 610961 449704 75408 85849 MISCELLANEOUS 200942 95850 66132 38960 EQUIPMENT AND MAINTENAN 60356 44884 7260 8212 43652 14159 1256 28237 42324633 33790769 3758034 4775830 11693111 1429770 8187638 17740483 20603233 15248869 298326 1382434 33467 62375 610114 1169049 5375769 4487703 1512621 888066 21969853 22769727 167052 163497 65075415 60854270 4017947 3741994 11519592 11394999 1950000 500598 514647 16038137 17601640 X 24661755 27275504 24375523 15977126 49037278 43252630 65075415 60854270 -5687358 -97290 0 X 0 1 X 1 0 X 34319563 35758286 53040826 41998701 35529596 200646972 34319563 35758286 53040826 41998701 35529596 200646972 39806240 160840732 453860 423003 553922 887064 907982 3225831 14854 450 20400 35704 203908507 2648991 0.78880 0.73360 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4939 93490 98429 38503340 38601769 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 249503 16895 232229 98429 597056 250000 250000 250000 250000 1000000 1500000 47215 6870 59150 4939 118174 SCHEDULE C, PART II-A OFFICE IN WASHINGTON DC ENGAGES IN DEVELOPING REPORT LANGUAGE FOR APPROPRIATIONS BILLS; DEVELOPING ALERTS TO OUR MEMBERS REGARDING SPECIFIC LEGISLATION; PREPARING FOR AND ATTENDING VISITS ON CAPITAL HILL BY OUR MEMBERS AND THE PUBLIC DURING ADVOCACY DAYS; GIVING UNINVITED AND INVITED TESTIMONY OR WRITTEN RESPONSES DURING LEGISLATIVE HEARINGS; DEVELOPING GENERAL EDUCATION MESSAGES THROUGH MEDIA CAMPAIGNS THAT DO OR DO NOT INCLUDE A CALL FOR ACTION. 872026 720853 151173 1154691 1034306 120385 3349052 2732544 616508 888066 CAPITAL LEASE OBLIGATIONS 3009 DEFERRED LEASE LIABILITY 511638 514647 X 36374163 -97290 -97290 36471453 165822 165822 36637275 42158811 0 42158811 165822 165822 42324633 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE LAWS. IN DECEMBER 2017, THE TAX CUTS AND JOBS ACT (THE ACT) WAS ENACTED, WHICH MAY RESULT IN ADDITIONAL UNRELATED BUSINESS TAXABLE INCOME ON CERTAIN FRINGE BENEFITS. THE ORGANIZATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS FILING STATUS OF TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE ORGANIZATION HAD NO MATERIAL NET UNRELATED BUSINESS INCOME REQUIRING RECOGNITION FOR THE YEARS ENDED JUNE 30, 2020 AND 2019. THE ORGANIZATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND CALIFORNIA STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. 1 0 0 0 0 0 0 0 0 0 NORTH AMERICA FUND RESEARCH 250000 CHECK 1 0 0 0 0 0 0 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS RESEARCH GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGIBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. THE PANCREATIC CANCER ACTION NETWORK HAS ESTABLISHED OTHER GRANT AGREEMENTS TO FUND SCIENTIFIC INITIATIVES IN CLINICAL TRIALS RESEARCH AND EARLY DETECTION OF PANCREATIC CANCER. PART III ACCOUNTING METHOD: WALKS AND RUNS 13027561 13027561 1228093 GALA 210410 210410 8785 19722 20500 13237971 13237971 8785 19722 1248593 1277100 -1277100 SCHEDULE G, PART I, LINE 3 THE ORGANIZATION IS REGISTERED TO FUNDRAISE IN EVERY STATE. IN FISCAL YEAR 2020, THE PROPER STATE REGISTRATION FORMS WERE FILED. 1 ROSWELL PARK COMPREHENSIVE CANCER CENTER ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 500000 FUND RESEARCH COLUMBIA UNIVERSITY MEDICAL CENTER 154 HAVEN AVENUE NEW YORK NY 10032 135598093 501(C)(3) 500000 FUND RESEARCH COLUMBIA UNIVERSITY MEDICAL CENTER 154 HAVEN AVENUE NEW YORK NY 10032 135598093 501(C)(3) 500000 FUND RESEARCH GEORGETOWN UNIVERSITY 2121 WISCONSIN AVENUE WASHINGTON DC 20057 530196603 501(C)(3) 500000 FUND RESEARCH RUTGERS THE STATE UNIVERSITY OF NEW JERSEY-RBHS-CINJ 33 KNIGHTBRIDGE 2ND FLOOR EAST WING WING PISCATAWAY NJ 08854 462354111 501(C)(3) 250000 FUND RESEARCH SANFORD BURNHAM PRESBYS MEDICAL DISCOVERY INSTITUTE 10901 NORTH TORREY PINES ROAD LA JOLLA CA 92037 510197108 501(C)(3) 250000 FUND RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 250000 FUND RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BOULEVARD LOS ANGELES CA 90048 951644600 501(C)(3) 200000 FUND RESEARCH BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 200000 FUND RESEARCH UNIVERSITY OF CHICAGO 6054 S DREXAL AVENUE CHICAGO IL 60637 362177139 501(C)(3) 200000 FUND RESEARCH UNIVERSITY OF CHICAGO 6054 S DREXAL AVENUE CHICAGO IL 60637 362177139 501(C)(3) 200000 FUND RESEARCH UNIVERSITY OF CINCINNATI 51 GOODMAN DRIVE CINCINNATI OH 45221 316000989 501(C)(3) 500000 FUND RESEARCH UNIVERSITY OF CINCINNATI 51 GOODMAN DRIVE CINCINNATI OH 45221 316000989 501(C)(3) 200000 FUND RESEARCH FRED HUTCHINSON RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 250000 FUND RESEARCH WEILL CORNELL MEDICINE 1300 YORK AVENUE NEW YORK NY 10065 131623978 501(C)(3) 120000 CLINICAL TRIALS RESEARCH BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON 1201 NINTH AVENUE SEATTLE WA 98101 910653422 501(C)(3) 120000 CLINICAL TRIALS RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE ONE PARK AVENUE 6TH FLOOR NEW YORK NY 10016 135562308 501(C)(3) 120000 CLINICAL TRIALS RESEARCH WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST LOUIS 660 SOUTH EUCLID AVENUE ST LOUIS MO 63110 430653611 501(C)(3) 120000 CLINICAL TRIALS RESEARCH UNIVERSITY OF FLORIDA 219 GRINTER HALL GAINESVILLE FL 32611 596002052 501(C)(3) 120000 CLINICAL TRIALS RESEARCH FRED HUTCHINSON RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 120000 CLINICAL TRIALS RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BOULEVARD LOS ANGELES CA 90048 951644600 501(C)(3) 120000 CLINICAL TRIALS RESEARCH CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BOULEVARD LOS ANGELES CA 90048 951644600 501(C)(3) 60000 CLINICAL TRIALS RESEARCH GENECENTRIC THERAPEUTICS INC 100 CAPITOLA DRIVE SUITE 275 DURHAM NC 27713 452540158 C CORPORATION 300000 CLINICAL TRIALS RESEARCH EGOG-ACRIN CANCER RESEARCH GROUP 1818 MARKET STREET SUITE 3000 PHILADELPHIA PA 19103 391723095 501(C)(3) 190416 CLINICAL TRIAL CORRELATIVE STUDY FRED HUTCHINSON RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 100000 EARLY DETECTION INITIATIVE 24 1 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS RESEARCH GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGIBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. THE PANCREATIC CANCER ACTION NETWORK HAS ESTABLISHED OTHER GRANT AGREEMENTS TO FUND SCIENTIFIC INITIATIVES IN CLINICAL TRIALS RESEARCH AND EARLY DETECTION OF PANCREATIC CANCER. SCHEDULE I, PART II GRANTS REPORTED ON SCHEDULE I, PART II ARE GREATER THAN GRANTS REPORTED ON FORM 990, PART IX, LINE 1 DUE TO PRIOR YEAR GRANT REFUNDS. FORM 990, PART IX, LINE 1 IS A NET AMOUNT OF CURRENT YEAR GRANTS AND PRIOR YEAR GRANT REFUNDS. SCHEDULE I, PART II TOTAL GRANTS 5,990,416 SCHEDULE F, PART II TOTAL GRANTS 250,000 PRIOR YEAR GRANT REFUNDS (236,568) ------------- FORM 990, PART IX, LINE 1 GRANTS 6,003,848 X X X X X X 1 1 0 0 0 0 0 0 0 JULIE FLESHMAN PRESIDENT & CEO/ DIRECTOR/EX-OFFICIO 404852 0 173701 0 6000 0 15425 0 14598 0 614576 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 286213 0 56183 0 0 0 11633 0 11613 0 365642 0 0 0 VICTORIA MANAX CHIEF MEDICAL OFFICER (FORMER) 296166 0 63000 0 0 0 15279 0 10204 0 384649 0 0 0 THOMAS CROAL CFO 258055 0 30000 0 15670 0 11380 0 19504 0 334609 0 0 0 SUDHEER DOSS CHIEF DATA OFFICER 318721 0 140000 0 0 0 12697 0 8641 0 480059 0 0 0 LORI STEVENS CHIEF DEVELOPMENT & COMMUNITY ENGAGE 258895 0 45905 0 0 0 10608 0 11628 0 327036 0 0 0 EDWINA MOSSETT CHIEF PEOPLE OFFICER 237179 0 45000 0 0 0 11475 0 10242 0 303896 0 0 0 CHRISTINE DITTMER VICE PRESIDENT, NATIONAL LEADERSHIP 247962 0 32477 0 0 0 10019 0 9140 0 299598 0 0 0 RICHARD LEONARD NATIONAL DIRECTOR, LEADERSHIP GIVING 221739 0 33057 0 0 0 9376 0 12366 0 276538 0 0 0 PART I, LINES 4A-B VICTORIA MANAX, $131,213 (SEVERANCE) JULIE FLESHMAN, $250,000 (457(F) PLAN - ACCRUED AT JUNE 30, 2020 AND PAID JULY 2020). X 1 235 FMV X 150 FMV X 90 333426 FMV X 400 FMV X SPORT & ENTERTAINMENT TICKETS 6 7041 FMV X TANGIBLE GOODS, GIFT CARDS 14 4037 FMV 0 1 0 PART I, COLUMN (B): THE NUMBER IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE AUDIT AND INVESTMENT COMMITTEE ("AIC") RECEIVES AND REVIEWS THE DRAFT OF THE FORM 990, INCLUDING SCHEDULES, PRIOR TO THE FILING OF THE RETURN. A MEETING OF THE AIC, INCLUDING THE PRESIDENT AND CEO, THE CFO, THE CONTROLLER, AND THE OUTSIDE CPA FIRM, IS THEN HELD TO REVIEW AND REVISE AS NECESSARY THE DRAFT OF THE FORM 990. UPON APPROVAL OF THE DRAFT FORM 990 BY THE AIC, THE FINAL FORM 990, WITH CHANGES REFLECTED, IF ANY, IS E-MAILED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING FOR ITS REVIEW. UPON ITS APPROVAL, THE FINAL FORM 990 IS FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT AN UPDATED CONFLICT OF INTEREST STATEMENT ON AN ANNUAL BASIS. TO THE EXTENT THAT RELATIONSHIPS ARE IDENTIFIED VIA THESE STATEMENTS AND OTHER INFORMATION, THE INDIVIDUAL'S CONSTITUENT RECORD IN THE COMPANY DATA BASE IS UPDATED TO INCLUDE THIS INFORMATION, FACILITATING PERIODIC QUERIES, AS NECESSARY. THE MEMBER WITH A CONFLICT MUST IDENTIFY THE CONFLICT AT ANY BOARD MEETING WHERE THE CONFLICT IS RELEVENT. THE MEMBER CANNOT BE PRESENT AT ANY PART OF THE MEETING WHERE THE RELEVENT TOPIC IS DISCUSSED OR VOTED ON. THE MEMBER CANNOT BE COUNTED FOR A QUORUM. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD COMPENSATION COMMITTEE IS RESPONSIBLE FOR THE REVIEW AND APPROVAL OF TOP-LEVEL EXECUTIVE MANAGEMENT COMPENSATION ANNUALLY. THE CHIEF PEOPLE OFFICER STAYS ABREAST OF INDUSTRY SALARY LEVELS AND ALERTS THE COMMITTEE TO ANY CHANGE IN SALARY LEVELS. INDEPENDENT PROFESSIONAL EXPERTS ARE CALLED UPON FOR HIGHER-LEVEL POSITIONS AND ASSIST IN ESTABLISHING EXECUTIVE SALARIES IN THE COMPETITIVE MARKETPLACE. SALARIES IN BOTH FOR PROFIT AND NOT FOR PROFIT ORGANIZATIONS ARE EVALUATED IN ORDER TO ATTRACT THE MOST TALENTED PERSONNEL. INFORMATION IS GATHERED, ANALYZED AND REPORTED TO THE COMMITTEE PRIOR TO THEIR MEETINGS ON COMPENSATION WITH THE INTENT OF ENSURING THAT THE EXECUTIVE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE REVIEW INCLUDES INCENTIVE PLANS AND ALL FRINGE BENEFITS AS WELL AS BASE SALARY ARRANGEMENTS. THE BOARD ESTABLISHES THE CEO/PRESIDENT SALARY LEVEL DURING THE EXECUTIVE SESSION OF A CALLED BOARD MEETING. ONCE APPROVED, EXECUTIVE COMPENSATION PACKAGES ARE FORMALIZED IN WRITING AND ONCE ACCEPTED BY THE EXECUTIVE, RETAINED IN THE EXECUTIVES' PERSONNEL FILE(S). FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION HAS A FORMAL POLICY FOR PUBLIC DISCLOSURE AND INSPECTION OF DOCUMENTS. THE POLICY IS POSTED ON THE ORGANIZATION'S WEB-SITE. FORM 990, PART IX, LINE 11G CLINICAL RESEARCH: PROGRAM SERVICE EXPENSES 7,462,166. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 7,462,166. PROFESSIONAL FEES - RECRUITMENT AND HR: PROGRAM SERVICE EXPENSES 61,728. MANAGEMENT AND GENERAL EXPENSES 9,255. FUNDRAISING EXPENSES 38,478. TOTAL EXPENSES 109,461. PROFESSIONAL FEES - PAYROLL AND ADMINISTRATION: PROGRAM SERVICE EXPENSES 12,792. MANAGEMENT AND GENERAL EXPENSES 1,918. FUNDRAISING EXPENSES 7,974. TOTAL EXPENSES 22,684. PROFESSIONAL FEES - FUNDRAISING CONSULTANT: PROGRAM SERVICE EXPENSES 203,014. MANAGEMENT AND GENERAL EXPENSES 30,438. FUNDRAISING EXPENSES 126,548. TOTAL EXPENSES 360,000. PROFESSIONAL FEES - 401K AUDIT: PROGRAM SERVICE EXPENSES 7,049. MANAGEMENT AND GENERAL EXPENSES 1,057. FUNDRAISING EXPENSES 4,394. TOTAL EXPENSES 12,500. PROFESSIONAL FEES - OTHER: PROGRAM SERVICE EXPENSES 1,102,544. MANAGEMENT AND GENERAL EXPENSES 165,303. FUNDRAISING EXPENSES 687,269. TOTAL EXPENSES 1,955,116. FORM 990 PART VI, LINE 10B COMPANY "AFFILIATES" CONSIST OF VOLUNTEERS WHO AGREE TO PERFORM THEIR VOLUNTEER ACTIVITIES IN COMPLIANCE WITH GUIDELINES PROVIDED IN A COMMUNITY OUTREACH AFFILIATE AGREEMENT. THERE ARE NO NON-VOLUNTEER AFFILIATES, CHAPTERS OR BRANCHES (E.G., NO LEGAL ENTITIES). FORM 990, PART VIII, LINE 8C THE PANCREATIC CANCER ACTION NETWORK AND THEIR NETWORK OF VOLUNTEER AFFILIATES HELD WALKS, RUNS, AND BIKE EVENTS ALL OVER THE NATION TO BOTH FUNDRAISE AND RAISE PUBLIC AWARENESS ABOUT PANCREATIC CANCER. ALL REVENUE RAISED FROM THE EVENTS ARE CONSIDERED TO BE CHARITABLE CONTRIBUTIONS. THE ENTITY DOES INCUR EXPENSES IN CONDUCTING THE EVENTS, BUT BECAUSE ALL INCOME IS CATEGORIZED AS CONTRIBUTION REVENUE, IT IS REPORTED AS A LOSS FROM SPECIAL EVENTS, EVEN THOUGH THE EVENT WAS PROFITABLE.